Navigation Links
Todd Rider Joins Draper to Continue Antiviral Therapeutics Development
Date:1/8/2014

Cambridge, MA (PRWEB) January 08, 2014

Todd Rider has joined Draper Laboratory to continue his work on treatments that are effective against a wide array of pathogens, rather than specific threats.

Rider received his Ph.D. from MIT in 1995 and served as a senior staff scientist at MIT Lincoln Laboratory until October 2013. While at Lincoln Laboratory, Rider began development of a broad-spectrum antiviral therapeutic drug called DRACO, which TIME Magazine hailed as one of the top inventions of the year 2011, and the White House described as “visionary” in its 2012 National Biotechnology Blueprint.

Upon administration to an animal or hopefully someday a person, Rider’s DRACO drug rapidly identifies virus-infected cells and eliminates them while leaving healthy cells untouched, thus eliminating the infection. DRACO, which stands for Double-stranded RNA Activated Caspase Oligomerizer, has proven effective and nontoxic in mice and in 11 different human and animal cell types against 15 different viruses, ranging from the common cold to dengue hemorrhagic fever.

Rider is expanding his DRACO research at Draper and is testing against strains of various other viruses in cells and animals; the team looks forward to larger scale animal trials and clinical human trials within a decade or less. DRACO is part of Rider’s PANACEA project, a family of broad-spectrum therapeutics that he invented.

Rider holds a joint appointment with MIT’s Edgerton Center, where he is also working to develop innovative programs to improve K-12 science education, drawing on his extensive previous experience creating and running educational outreach programs at Lincoln Laboratory.

Draper Laboratory

Draper Laboratory, which celebrates 80 years of service to the nation in 2013, is a not-for-profit, engineering research and development organization dedicated to solving critical national problems in national security, space systems, biomedical systems, and energy. Core capabilities include guidance, navigation and control, miniature low power systems, highly reliable complex systems, information and decision systems, autonomous systems, biomedical and chemical systems, and secure networks and communications.

http://www.draper.com

Read the full story at http://www.prweb.com/releases/2014/01/prweb11469349.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. "Just Label It" condemns dangerous riders snuck into the Farm Bill by chemical companies working to keep Americans in the dark about their food
2. Jesper Bramming, former A.P. Moller Executive, Joins the CMC Biologics Executive Management Team as Chief Financial Officer
3. Dr. Daniel Von Hoff Joins Lixte Biotechnologys Scientific Advisory Board
4. Bioentrepreneurship Leader Joins UM Ventures Team
5. Anthony A. Charity Joins Tunnell Consulting
6. CHI Joins More Than 30 State Life Sciences Associations in Urging Budget Conferees to Fix FDA User Fee Sequester
7. Craig Peloquin Joins Glissandra Skin Care as VP of Sales and Marketing
8. General Patent Corporation Chairman and CEO Alexander Poltorak Joins Spherix Board Industry veteran and authority on patent law and valuation joins Spherix as director
9. Dr. Ungerleider Joins Forces with Childhelp
10. ReachMD Radio Joins Clear Channel’s iHeartRadio
11. Soltex Consulting Joins Medidata Partner Program to Better Optimize Clinical Processes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
Breaking Biology Technology:
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
Breaking Biology News(10 mins):